FDA Approves Futuristic New Cancer Therapy, To Cost $475,000, Sending Biotechs Surging
August 30, 2017 at 16:27 PM EDT
News of the CAR-T's approval sent the Nasdaq Biotech index surging to its biggest gain since June 21, up as much as 2.3%.
